Am. J. Respir. Cell Mol. Biol., Volume 19, Number 4, October, 1998 629-635

Tumor Necrosis Factor- Stimulates Human Clara Cell Secretory Protein Production by Human Airway Epithelial Cells

X. L. Yao, S. J. Levine, M. J. Cowan, C. Logun, and J. H. Shelhamer

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland

Clara cell secretory protein (CCSP), or CC10, is an inhibitor of secretory phospholipase A₂ which may be produced by phagocytic cells and by a variety of other cells in the airway. Tumor necrosis factor- (TNF-) is capable of activating phospholipases and inducing the expression of a variety of genes in the airway epithelium which may modulate the airway inflammatory response. Therefore, it was of interest to determine whether this proinflammatory cytokine could induce the production of a counterregulatory protein such as CCSP which might modulate the production of eicosanoid mediators in the airway. Using a human bronchial epithelial cell line (BEAS-2B), CCSP messenger RNA (mRNA) levels were detected by ribonuclease protection assay. TNF treatment of these cells increased CCSP mRNA levels in a time- and dose-dependent manner. The CCSP mRNA level increased in response to TNF- (20 ng/ml) stimulation after 8 to 36 h with the peak increase at 18 h. Immunoblotting of CCSP protein released into the culture media demonstrated that TNF- induced the synthesis and secretion of CCSP protein in a time-dependent manner over 8 to 18 h. The results of a CCSP reporter gene activity assay, nuclear run-on assay, and CCSP mRNA half-life assay indicated that the TNF--induced increases in CCSP gene expression are regulated at the post-transcriptional level. We conclude that TNF- induces airway epithelial cell expression of human CCSP protein and may modulate airway inflammatory responses in this manner.

This article has been cited by other articles:

				J. Chen, S. Lam, A. Pilon, A. McWilliams, C. MacAulay, and E. Szabo Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer Clin. Cancer Res., March 1, 2008; 14(5): 1590 - 1597. [Abstract] [Full Text] [PDF]

				B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF]

				R. Janssen, H. Sato, J. C. Grutters, H. J. T. Ruven, R. M. du Bois, R. Matsuura, M. Yamazaki, S. Kunimaru, T. Izumi, K. I. Welsh, et al. The Clara Cell10 Adenine38Guanine Polymorphism and Sarcoidosis Susceptibility in Dutch and Japanese Subjects Am. J. Respir. Crit. Care Med., December 1, 2004; 170(11): 1185 - 1187. [Abstract] [Full Text] [PDF]

				P. L. Ramsay, Z. Luo, S. M. Magdaleno, S. K. Whitbourne, X. Cao, M. S. Park, S. E. Welty, L.-Y. Yu-Lee, and F. J. DeMayo Transcriptional regulation of CCSP by interferon-gamma in vitro and in vivo Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L108 - L118. [Abstract] [Full Text] [PDF]

				S. Kim, J. J. Shim, P.-R. Burgel, I. F. Ueki, T. Dao-Pick, D. C.-W. Tam, and J. A. Nadel IL-13-induced Clara cell secretory protein expression in airway epithelium: role of EGFR signaling pathway Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L67 - L75. [Abstract] [Full Text] [PDF]

				K. S. Harrod and R. J. Jaramillo Pseudomonas aeruginosa and Tumor Necrosis Factor-alpha Attenuate Clara Cell Secretory Protein Promoter Function Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 216 - 223. [Abstract] [Full Text] [PDF]

				T. M. Watson, S. D. Reynolds, G. W. Mango, I.-M. Boe, J. Lund, and B. R. Stripp Altered lung gene expression in CCSP-null mice suggests immunoregulatory roles for Clara cells Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1523 - L1530. [Abstract] [Full Text] [PDF]

				M. J. COWAN, X. HUANG, X. L. YAO, and J. H. SHELHAMER Tumor Necrosis Factor Alpha Stimulation of Human Clara Cell Secretory Protein Production by Human Airway Epithelial Cells Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 193 - 201. [Abstract] [Full Text] [PDF]

				A. L. PILON Rationale for the Development of Recombinant Human CC10 as a Therapeutic for Inflammatory and Fibrotic Disease Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 280 - 299. [Abstract] [Full Text] [PDF]

				S. Hayashida, K. S. Harrod, and J. A. Whitsett Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L452 - L459. [Abstract] [Full Text] [PDF]